Re-cyclization of 3-(E)-methyl 3-(4-oxo-4H-chromen-3-yl)acrylate with amines and their potential mechanism
摘要:
The synthesis of 2-pyridone derivatives from different substituted amines and various 3-(E)-methyl 3-(4-oxo-4H-chromen-3-yl)acrylate derivatives was proposed and described. The optimized reaction conditions and the generality of the reaction were investigated, respectively. Moreover, less side products could be formed than the traditional method. Finally, based on the fact that (E)-methyl 2-(7-methoxy-4-oxo-3-((phenylamino)methylene)chroman-2-yl)acetate was separated and determined via X-ray single crystal diffraction, we could propose an interesting and reasonable reaction mechanism for the first time. The reaction could render this method particularly attractive for the efficient preparation of biologically and medicinally interesting molecules. (c) 2013 Elsevier Ltd. All rights reserved.
Synthesis and anti-HBV activity of novel 5-substituted pyridin-2(1H)-one derivatives
作者:Yi Kai Zhang、Zhi Liang Lv、Chun Juan Niu、Ke Li
DOI:10.1016/j.cclet.2009.10.010
日期:2010.3
Abstract Four novel 5-substituted pyridine-2(1H)-onederivatives were designed and synthesized by using addition–elimination reactions. The structures of these novelly synthesized compounds were verified by 1 H NMR, ESI-MS and single crystal X-ray diffraction. Furthermore, all four compounds (most notably compound 7a ) were found to be highly efficient against hepatitis B virus (HBV) in cultured HepG2
摘要设计了四种新的5-取代吡啶-2(1H)-one衍生物,并通过加成-消除反应合成。这些新颖合成的化合物的结构通过1 H NMR,ESI-MS和单晶X射线衍射验证。此外,发现所有四种化合物(最显着的化合物7a)在培养的HepG2 2.2.15细胞中对乙型肝炎病毒(HBV)都非常有效,这使其成为抗乙型肝炎潜在生物活性分子的有希望的候选药物。
Design, Synthesis, and Antihepatitis B Virus Activities of Novel 2-Pyridone Derivatives
A series of novel 2-pyridone derivatives were synthesized and evaluated for their antihepatitis B virus (HBV) activity and cytotoxicity in vitro. Moderate to good activity against HBV DNA replication was observed in these 2-pyridone analogues. The most active compounds were 5d and 61, with good inhibitory activity against HBV DNA replication (IC50 = 0.206 and 0.12 mu M, respectively) and remarkable high selectivity (selectivity indexes of >532 and 467, respectively). A pharmacophore model of the synthesized compounds was proposed by the GASP program. The pharmacophore model consists of three hydrophobic points, four HBA points, and one HBD point. The 2-pyridone derivatives represent a novel class of HBV inhibitors, which are worth further optimization.